Clinical Trial Update: The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating screening for high on-treatment platelet reactivity (HPR) in patients undergoing lower-extremity arterial endovascular interventions …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Occlusive Disease
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Marissa Jarosinski | Conditions: Peripheral Artery Disease, Clopidogrel, Poor Metabolism of | Phase 3 | Status: TERMINATED | Results posted: 2026-02-13